 ICRF ChaptersFOR IMMEDIATE RELEASE
Contact: Diana Lopez, CMN
dlopez@cmnevents.com, 312-492-6424
Judith Labowitz, ICRF
judyl@icrfchicago.org, 847-867-1948
Israel Cancer Research Fund Todah Rabah Gala to be
Held Nov. 9 at the Hyatt Regency Chicago
Steven T. Rosen, MD, FACP to Receive Special Tribute
CHICAGO (September 8, 2011) – The Israel Cancer Research Fund (ICRF) Chicago Chapter has announced that it will hold its annual Todah
Rabah (“Thank You,” in Hebrew) Gala on Wednesday, Nov. 9 at the Hyatt Regency Chicago’s Crystal Ballroom beginning at 6:30 p.m. This year, ICRF
will pay a special tribute to Steven T. Rosen MD, FACP, Genevieve Teuton Professor of Medicine, at the Feinberg School of Medicine, Northwestern
University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Broadcast journalists Jay Levine and Mary Ann
Childers will serve as this year’s emcees, while Chicago native and actress Bonnie Hunt is set to make a special appearance. Co-Chairs for this year’s
Todah Rabah Tribute Gala are: Bruce Barron, Paul Fox, Shirley Ryan, Patrick Ryan, Ted Schwartz, Keith Shapiro and Sam Skinner.
Dr. Rosen, who also serves as the Director of Cancer Programs at Northwestern Memorial Hospital, is acknowledged in Best Doctors in America and Best
Doctors in Chicago.
“We are ecstatic about paying tribute to one of today’s finest advocates in the fight against cancer,” said Ken Goodman, Chairman of the Board of the
ICRF and Presiding Director of Forest Laboratories. “Dr. Rosen is tireless in his mission and he has been an outstanding ambassador for ICRF. We are
proud of his exceptional contributions to the oncology field and are honored to call him a friend. He is not only a dedicated professional, but also a
compassionate person who has helped save the lives of countless people.”
Dr. Rosen’s world-renowned work spans more than 30 years and his laboratory research focuses on experimental therapeutics and hematologic
malignancies.
“I have deep respect for the scientific community in Israel and the work of ICRF. I am honored to be the recipient of this year’s Todah Rabah Tribute from
ICRF,” said Dr. Rosen.
To purchase tickets to the ICRF Gala, please contact Judith Labowitz at 847-867-1948 or via email: judyl@icrfchicago.org.
For more information, please
visit the ICRF Gala Facebook page at http://www.facebook.com/event.php?eid=192490500819605.
About Steven T. Rosen, MD, FACP
Following his graduation with distinction from Northwestern University Medical School’s Six-Year Honors Program in 1976, Dr. Rosen completed his
residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr. Rosen has received numerous
grants awards and contracts and has published more than 300 scientific papers. As Director of the Cancer Center, Dr. Rosen has successfully competed
for an NCI Cancer Center Support Grant, NCI grants for his laboratory research, an NCI RAID Contract grant for the development of a novel purine
analog, and grants from the Leukemia and Lymphoma Society of America and the American Cancer Society. Dr. Rosen is the Co-Principal Investigator of
Northwestern’s NCI Center for Cancer Nanotechnology Excellence Grant. Dr. Rosen serves on several editorial boards and is editor of Cancer Treatment& Research. He is a member of all major national associations that focus on oncology and has held leadership positions in the Eastern Cooperative
Oncology Group, the American Association of Cancer Institutes and the National Comprehensive Cancer Network. He serves on the advisory boards of
several NCI-designated Cancer Centers, the Leukemia and Lymphoma Society of America, the Multiple Myeloma Research Foundation, the Lymphoma
Research Foundation and the Wendy Will Cancer Research Foundation. He has also served as an advisor to Great Britain’s Cancer Research
Campaign. Dr. Rosen was the recipient of Northwestern University Medical School’s Alumni Achievement Award (1994), the Martin Luther King
Humanitarian Award from Northwestern Memorial Hospital (1995), the Marv Samuel Award from the Chicago Baseball Cancer Charities (1996) and
recognition from the Women’s Board of Northwestern Memorial Hospital for Compassionate Care (1996).
About ICRF
The Israel Cancer Research Fund (ICRF) is a voluntary charitable organization that receives its total income from private donations. ICRF was founded in
1975 by a group of American and Canadian researchers, oncologists, and lay people determined to harness Israel's educational and scientific resources
in the fight against cancer. Its initial purpose was to stem the "brain drain" of Israeli researchers by providing funds for postdoctoral fellowships for young
Ph.D.'s. ICRF is the only U.S.-based charity solely devoted to supporting cancer research in Israel. Since its inception, ICRF has provided more than $40
million to support innovative scientific research by Israeli scientists. ICRF-funded researchers have been making significant progress and have been able
to develop improved chemotherapies, advanced techniques in bone marrow transplantation, and an enhanced understanding of tumor suppressor genes.
Two ICRF funded scientists, Drs. Avram Hershko and Aaron Ciechanover, received the first Nobel Prize in Chemistry awarded to Israel (2004). Their
discovery of a process known as the ubiquitin system, which allows cells to destroy unwanted proteins, led to a groundbreaking new treatment (Velcade)
for multiple myeloma, a cancer of the bone marrow.
www.cmnevents.com
|
